[世界核]
Fukushima Session
The progress of development of At-211 targeted alpha particle therapy at Fukushima Medical University and possibilities of combined therapy with external-beam radiation and immunotherapy
2022年9月9日(金) 17:30 〜 18:30 第1会場 (国立京都国際会館 1F Main Hall)
Chair：Shunichi Yamashita (Vice president, Fukushima medical university, Fukushima, Japan), Tohru Shiga (Advanced clinical Research Center, Fukushima medical university, Fukushima, Japan)
Shunichi Yamashita、Tohru Shiga、Koshin Washiyama、Kazuhiro Takahashi、Yoshiyuki Suzuki (Research Center, Fukushima medical university, Fukushima, Japan)
-
スケジュール
Kazuhiro Takahashi (Advanced clinical Research Center, Fukushima medical university, Fukushima, Japan)
-
スケジュール
Yoshiyuki Suzuki (Advanced clinical Research Center, Department of Radiation Oncology, Fukushima medical university, Fukushima, Japan)
-
スケジュール